Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

September

American Cancer Society – Professor Award

• Due: September 1, 2025 (LOI)
• Funding: Up to $80,000 per year
• Project Period: 5 years
• Purpose: To honor full professors who have made seminal contributions to the field of cancer research and will continue to make impactful contributions to change the direction of research. Commitment and success in scientific mentoring and leadership, and community engagement will be considered.
• Eligibility: For full professors.

Cancer Research Institute – CRI Irvington Postdoctoral Fellowships

• Due: September 1, 2025
• Funding:stipend $74,000 year 1; $76k year 2; $78k year 3
• Project Period: Up to 3 years
• Purpose: To support hypothesis-driven, mechanistic studies by qualified early career scientists at leading universities and research centers worldwide, who seek training in fundamental immunology or cancer immunology.
• Eligibility: Applicants must have a doctorate degree with 5 or more years of relevant postdoctoral experience (M.D. applicants should not include years of residency in this calculation) and be working in areas directly related to immunology or cancer immunology at a non-profit institution. Completion of eligibility questionnaire required.
  Note: CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
  CRI Immuno-Informatics Postdoctoral Fellowship

American Heart Association – Postdoctoral Fellowships

• Due: September 4, 2025
• Funding: Annual stipend $62,232 – $75,564 based on years of experience + $12,200 annually (for health insurance), and $3,000 per year for project support
• Project Period: Up to 2 years; 2-year renewal available based on research progress
• Purpose: To enhance the training of postdoctoral researchers who are not yet independent.
• Eligibility: Applicants must hold an MD, PhD, DMD, DO, PharmD, DVM, PhD in nursing or equivalent from an accredited institution, (with no more than five years of research training after obtaining a doctorate degree prior to application submission). Applicant fellowship positions must be at university affiliated institutions or other non-profit research institutions within the United States and U.S. possessions (U.S. citizenship or permanent residency, or appropriate work visas and permits required). 80% protected time required. This award is not for individuals of faculty rank. Awards are limited to U.S.-based non-profit institutions. An awardee must maintain an AHA-accepted visa through the duration of the grant.

Simons Foundation – SFARI Data Analysis

• Due: September 4, 2025
• Funding: $300,000
• Project Period: 2 years
• Purpose: Supports research that leverage existing publicly accessible datasets to explore new questions and extract new knowledge. Priority will be given to proposals that use SFARI-supported resources.
• Eligibility: All applicants and collaborators must hold a PhD, MD or equivalent degree and a faculty position or equivalent at a college, university, medical school or other research facility. Applicants may have autism research experience or be new to the field and interested in asking new questions in existing datasets.

Arnold & Mabel Beckman Foundation – Arnold O. Beckman Postdoctoral Fellowship

• Due: September 5, 2025 (LOI)
• Funding: $224,000
• Project Period: 2 years
• Purpose: The Arnold O. Beckman Postdoctoral Fellowship in Chemical Sciences or Chemical Instrumentation Award Program supports for advanced research by postdoctoral scholars working within the core areas of fundamental chemistry or the development and build of chemical instrumentation. An optional third year is available based on progress, with $118,000 of funding for salary, fringe and research expenditures.
• Eligibility: Visa holders are not eligible to apply. Current graduate students with an anticipated PhD completion date by May 1, 2026, or current postdoctoral researchers in the chemical sciences with no more than 18 months of research experience are eligible. Candidates must have a sponsoring mentor (or co-mentor) who holds a PhD or MD/PhD, is a full-time tenured or tenure-track (or equivalent) faculty with at least a 25% appointment in a department affiliated with chemistry, chemical physics, chemical engineering, or the chemistry of materials science at a U.S-based institution. Candidates must pursue postdoctoral research training in one of the aforementioned areas. U.S. citizens or permanent residents of the United States or its possessions or hold Deferred Action for Childhood Arrivals (DACA) recipient status eligible. Check other eligibility requirements.

American Academy of Neurology  – Career Development Award

• Due: September 9, 2025
• Funding: $450,000
• Project Period: 3 years
• Purpose: To support early career investigators pursuing an academic career in clinical, basic, or translational neurologic research.
• Eligibility: AAN members who are neurologists and completed residency between 5-10 years prior to award start date (July 1, 2026). MD/PhDs and fellows post residency are eligible based on residency completion date.

American Academy of Neurology, American Brain Foundation & ALS – Clinical Research Training Scholarships

• Due: September 9, 2025
• Funding: $150,000
• Project Period: Up to 2 years
• Purpose: To recognize the importance of good clinical research and to encourage early career investigators who are interested in an academic career in neurological research to conduct clinical studies in clinical research in neurology and more specific areas such as ALS, Frontotemporal Degeneration (FTD), and other neurological disorders. AAN funding will be provided in collaboration with various partners.Areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research. Disease-related research not involving human subjects will be considered it the goal is to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
• Eligibility: PI must have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 5 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These awards also seek to encourage early career scientists to pursue and establish careers patient-oriented research in the various areas of neurological research.
  Clinical Research Training Scholarship – to cover education and research-related costs.
  Clinical Research Training Scholarship in ALS – Partnership funding provided with The ALS Association & the American Brain Foundation for clinical research studies in ALS.
  Clinical Research Training Scholarship in FTD – Partnership funding provided with the Holloway Family Fund of The Association for Frontotemporal Degeneration and the American Brain Foundation for clinical studies in FTD by clinical care providers interested in pursuing careers in patient-oriented research.
  Clinical Research Training Scholarship in Lewy Body Diseases – Partnership funding provided with the Alzheimer’s Association and the American Brain Foundation for clinical research with early career investigators in Lewy body diseases.
  Clinical Research Training Scholarship in Mal de Debarquement Syndrome and Central Vestibular Neurological Disorders – Partnership funding provided by the MdDs Balance Disorder Foundation and the American Brain Foundation for research studies in Mal de Debarquement Syndrome and Central Vestibular Neurological Disorders.
  Clinical Research Training Scholarship in Parkinson’s Disease – Partnership funding with the Parkinson’s Foundation and the American Brain Foundation for clinical studies in Parkinson’s disease.
  Clinical Research Training Scholarship in Peripheral Neuropathy – Partnership funding with the Foundation for Peripheral Neuropathy and the American Brain Foundation for studies focused on furthering understanding of disease mechanisms, diagnosis, or treatment of peripheral neuropathy.
  Jeanne C. Mayer Multiple Sclerosis Research Award – Partnership funding with the Herbert R. Mayer and Jeanne C. Mayer Foundation through the American Brain Foundation for clinical studies related to multiple sclerosis.
  Lawrence M. Brass, MD, Clinical Research Training Scholarship in Stroke – Partnership funding with the American Heart Association and the American Brain Foundation for clinical studies related to stroke, vascular neurology, and neurocritical care.
  McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss – Partnership funding with the McKnight Brain Research Foundation through the American Brain Foundation for studies relevant to age-related cognitive decline and memory loss.
  Robert Katzman, MD, Clinical Research Training Scholarship in Alzheimer’s and Dementia Research – Partnership funding with the Alzheimer’s Association and the American Brain Foundation for clinical studies related to Alzheimer’s and related dementias.
  Susan S. Spencer, MD, Clinical Research Training Scholarship in Epilepsy – Partnership funding with the American Epilepsy Society, Epilepsy Foundation, and the American Brain Foundation for clinical research training in the field of epilepsy conducted by clinicians who are fellows or new faculty.

American Academy of Neurology  – Clinician Scientist Development Award in Myasthenia Gravis

• Due: September 9, 2025
• Funding: $240,000
• Project Period: 3 years
• Purpose: In partnership with the Myasthenia Gravis Foundation of America and the American Brain Foundation to support clinical research research studies related to myasthenia gravis.
• Eligibility: PIs must be an AAN member with interest in an academic career in neurological research and have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 5 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

American Academy of Neurology  – Neuroscience Research Training Scholarship

• Due: September 9, 2025
• Funding: $150,000
• Project Period: 2 years
• Purpose: To encourage young investigators in good laboratory or preclinical research and support education and research-related costs.
• Eligibility: Applicants must be interested in a career in neurological research and hold an MD, PhD, or equivalent doctoral-level clinical degree and have completed residency between 5-10 years prior to award start date (July 1, 2026) are eligible. MD/PhDs and post residency fellows’ eligibility is based on residency completion date. Research for this scholarship is defined as patient-oriented research conducted with human subjects or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. However, disease-related studies not directly related to huma subjects or human tissue are still encouraged if the primary goal is to develop therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.

American Academy of Neurology  – Practice Research Training Scholarship

• Due: September 9, 2025
• Funding: $150,000
• Project Period: 2 years
• Purpose: To support practice-based research (clinical research that evaluates translation of evidence into best clinical practice), which includes evaluation of health services, quality of care, implementation of therapies, physician performance, or patient adherence, to improve health systems and services.
• Eligibility: AAN members interested in a career in neurological research who hold an MD, PhD, or equivalent doctoral-level clinical degree and have completed residency between 5-10 years prior to award start date (July 1, 2026) are eligible. MD/PhDs and post residency fellows eligibility is based on residency completion date.

American Academy of Neurology  –Richard Olney Clinician Scientist Development Award in ALS

• Due: September 9, 2025
• Funding: $240,000
• Project Period: 3 years
• Purpose: To support young investigators conducting clinical research studies in ALS.
• Eligibility: PIs must have an MD, PhD, or equivalent doctoral-level clinical degree (with completed clinical residency or PHD no more than 7 years prior to July 1, 2026). For MD/PhDs eligibility is based on residency completion date even if a fellowship was completed afterwards. Research should be patient-oriented conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease.

Pfizer External Research & Grants and the American Gastroenterological Association (AGA) – New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease RFP

• Due: September 11, 2025
• Funding: Up to $60,000
• Project Period: Up to 1 year
• Purpose: To support proposals focused on new research areas that could improve the diagnosis and treatment of inflammatory bowel disease (IBD).
• Eligibility: AGA membership required for PI. For PIs at an institution based in the U.S., who have an MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. The requesting organization must be legally able to receive funding directly from Pfizer Inc.

Alzheimer’s Drug Discovery Foundation – Drug Development RFP

• Due: September 15, 2025 (LOI)
• Funding: Up to $5,000,000
• Project Period: Multi-year year
• Purpose: To support new drug (IND)-enabling studies (or international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices to treat Alzheimer’s disease (AD) and related dementias. This grant mechanism focuses on diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia.
• Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies may apply. Industry partnerships are encouraged.

Alzheimer’s Drug Discovery Foundation – Neuroimaging and CSF Biomarker Program

• Due: September 15, 2025 (LOI)
• Funding: Up to $600,000
• Project Period: 1 year (potential for follow-on funding based on progress)
• Purpose: To provide funding and project support  to further develop and validate established biomarkers to meet clinical needs in Alzheimer’s disease and related dementias. Priority focus: developing novel PET ligands for clinical trials, validating innovative MRI approaches in larger cohorts, and developing novel measures of functional activity such as EEG.
• Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies. Industry partnerships are encouraged.

Alzheimer’s Drug Discovery Foundation – Prevention

• Due: September 15, 2025 (LOI)
• Funding: Up to $5,000,000
• Project Period: Multi-year year
• Purpose: To support precision prevention studies (in humans), combination therapy studies, and comparative effectiveness research that explore whether the use or choice of interventions reduces the risk of Alzheimer’s disease or other dementias.
  
• Eligibility: Applicants from academic medical centers, universities, nonprofit organizations, and biotechnology companies. Industry partnerships are encouraged.

American Philosophical Society – Daland Fellowships in Clinical Investigation

• Due: September 15, 2025
• Funding: $40,000
• Project Period: 1 year (possible renewal for 1 year if satisfactory progress demonstrated)
• Purpose: Supports research in the several branches of clinical medicine, including internal medicine, neurology, pediatrics, psychiatry, and surgery with emphasis on patient-oriented research.
• Eligibility: For individuals holding an MD, DO, MD/PhD, or DO/PhD less than 8 years (though intended to be the first post-clinical-training fellowship, each case will be decided on merits). Preference is usually given to candidates with no more than two years of postdoctoral training and research. Research must be performed in the U.S., and direct contact with patients is mandatory. 3 letters of support are required (scientific advisor, department/division head, an additional expert in the field).

William T. Grant Foundation – Institutional Challenge Grant

• Due: September 15, 2025
• Funding: $650,000
• Project Period: 3 years
• Purpose: Supports research institutions in building sustained research-practice partnerships with public agencies or nonprofit organizations to improve outcomes for all youth.
• Eligibility: Awards limited to tax-exempt organizations (university-based research institutes, schools, or centers). Eligible PIs should be leaders at eligible research institutions. Check eligibility requirements.

American Gastroenterological Association (AGA) – AGA-Beyond Celiac Pilot Research Award in Celiac Disease

• Due: September 18, 2025
• Funding: $40,000
• Project Period: 1 year
• Purpose: To help early career investigators establish their research careers or to support projects that represent new research directions for established investigators, in celiac disease or gluten-related disorders. For early career applicants this will be a mentored research project. Early career defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent) at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
• Eligibility: AGA members who hold an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible. Early career is defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.

American Gastroenterological Association (AGA) – AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer

• Due: September 18, 2025
• Funding: $40,000
• Project Period: 1 year
• Purpose: To provide supplemental funding for early career investigators who currently hold federal or non-federal career development awards focused on conducting research related to pathogenesis, prevention, diagnosis or treatment of digestive cancer. Early career defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.
• Eligibility: AGA members who hold an NIH K series or other federal or non-federal career development award of at least four years in duration, have an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible. Early career is defined as MDs no more than 7 years past completion of clinical training (GI fellowship or its equivalent) at the start date of this award, or a PHD applicant with no more than 7 years post their terminal PhD degree by the start date of this award.

American Gastroenterological Association (AGA) – AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer

• Due: September 18, 2025
• Funding: $100,000
• Project Period: 2 years
• Purpose: To support an established investigator in the gastric cancer research field who is working to enhance fundamental understanding of gastric cancer pathobiology or approaches to prevent, treat or cure gastric cancer.
• Eligibility: Independent investigators (AGA members) in the gastric biology field following the completion of clinical training as a GI fellow or equivalent, who hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO, seven years or more past clinical training or PhD completion) and a full-time faculty appointment or equivalent position at an institution in the United States, Canada or Mexico are eligible.

American Gastroenterological Association (AGA) – AGA Pilot Research Award

• Due: September 18, 2025
• Funding: $40,000
• Project Period: 1 year
• Purpose: To support independent early career investigators and established investigators  new directions in gastroenterology- or hepatology-related areas.
• Eligibility: Applicants must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico). AGA membership required.

American Chemical Society (ACS) – Principal Investigator Development in Sustainability

• Due: September 19, 2025
• Funding: $50,000
• Project Period: 1 year
• Purpose: To support independent early career investigators and established investigators  new directions in gastroenterology- or hepatology-related areas.
• Eligibility: Applicants must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and a full-time faculty position or equivalent at an institution in North America (U.S., Canada or Mexico). AGA membership required.

Pfizer and the American College of Emergency Physicians (ACEP) – Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management RFP

• Due: September 29, 2025
• Funding: Up to $200,000
• Project Period: Up to 2 years
• Purpose: To support projects focused on clinical program development that overcome barriers to safe, evidence-based management, disposition, and follow up of this patient population.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement with the target audience being emergency physicians treating adult patients presenting with symptoms of migraine in the ED. PIs must be an employee or contractor of the organization applying.

Bay Area Lyme Foundation  – Research Grants

• Due: September 30, 2025
• Funding: Not specified
• Project Period: Not specified
• Purpose: To support projects focused on research and development of novel diagnostics and treatments for Lyme Disease.
• Eligibility: Applications from universities, hospitals, and independent research entities throughout the U.S. (U.S. only) will be accepted. Previous research experience in Lyme Disease research is not necessary; respected researchers in their fields may leverage their knowledge, abilities, and resourcefulness to develop new concepts, ideas, and methods.

Benign Essential Blepharospasm Foundation – Research Grant

• Due: September 30, 2025
• Funding:stipend Up to $50,000
• Project Period: 1 year
• Purpose: To support research focused on causes, cures, and treatment for blepharospasm.
• Eligibility: Applicants must work at an organization located within the U.S., Canada, or countries where supervision of grant administration is possible. Grantee institution must agree to be bound by the Terms and Conditions of the application.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Advanced Fellowships

• Due: September 30, 2025
• Funding: $75,000
• Project Period: 1 year
• Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
• Eligibility: NASPGHAN membership for at least 2 years and a mentor is required.
  – NASPGHAN Foundation/Abbott Advanced Fellowship Training In Pediatric Nutrition – researchareas to include but are not limited to fetal growth and neonatal nutrition, typical development of feeding skills/behaviors and feeding disorders; nutritional aspects of eating disorders such as anorexia nervosa and bulimia; malnutrition and failure to thrive; nutrition education; nutrition in specific systemic diseases or clinical states such as cystic fibrosis, liver disease, intestinal failure, and organ transplantation; nutrition support; community nutrition; nutrition epidemiology; energy homeostasis; nutrition and the microbiome; micronutrient homeostasis; nutrigenomics; obesity; breast milk and breast feeding; and basic laboratory nutritional science.
  – NASPGHAN Foundation Advance Fellowship Training in Pediatric Endoscopy – for focused a research/and or quality improvement project in areas including but not limited to Endoscopic retrograde cholangiopancreatography (ERCP) with stenting and/or sphincterotomy, endoscopic ultrasound (EUS), advanced approaches to control GI bleeding (sclerotherapy, argon laser, clips, etc), transnasal endoscopy, peroral endoscopic myotomy (POEM), esophageal or intestinal stricture dilatation, pancreatic pseudocyst drainage, etc.

Wellcome – Early Career Awards

• Due: September 30, 2025
• Funding: Salary and up to £400,000
• Project Period: Up to 5 years (part-time available)
• Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
• Eligibility: Early career researchers ready to design, plan and deliver their own innovative projects. Applicants must hold a PhD or an equivalent higher research degree or at least four years’ equivalent research experience in the humanities and social sciences. Applicants who have no more than 3 years postdoctoral experience or researchers making a shift to a different research discipline may apply.

October

Pfizer External Research & Grants (ER&G) – Independent Medical Education Request for Proposals (RFP) Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)

• Due: October 1, 2025
• Funding: Up to $10,000 to $250,000
• Project Period: Up 18 months
• Purpose: To support proposals that focus on treatment optimization in the first-line maintenance setting and the evolving MBC therapeutic landscape to increase understanding of the role and value of maintenance therapy to allow clinicians to make informed treatment decisions.
• Eligibility: U.S.-based medical, allied health, and/or pharmacy professional schools; hospitals and healthcare institutions; professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible to apply. Target audience: Community medical oncologists, oncology nurses and nurse practitioners, physician assistants, pharmacists and other healthcare professionals involved in the care and treatment of people with MBC. If continuing education credit will be offered, the requesting organization must be accredited.

Pfizer External Research & Grants (ER&G) – Upskilling Advanced Practice Providers (APPs) on Actionable Biomarker and Genetic Testing in Cancer RFP

• Due: October 1, 2025
• Funding: $100,000 to $250,000
• Project Period: Up to 2 years
• Purpose: To support independent medical education provider organizations interested in teaching Physician Assistants,Nurse Practitioners and other allied healthcare professionals on the patient care team about advances in the use of biomarkers and genetics to inform treatment decision making in oncology.
• Eligibility: Medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. Only organizations in the U.S. are eligible to receive grants.

Acoustical Society of American  – 2026-27 F. V. Hunt Postdoctoral Research Fellowship in Acoustics

• Due: October 6, 2025
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: In honor of Dr. Hunt, this award supports advancing the science of, and education in acoustics.
• Eligibility: Applicants must have received a doctoral degree no earlier than 2024 or will be receiving one no later than April of 2026. Membership is required before candidates can apply. Applicants must have permanent residence or citizenship in the United States or Canada at the time of application.

November

Aniara Diagnostica  – Coagulation Research Grant

• Due: November 1, 2025
• Funding: $20,000
• Project Period: 1 year
• Purpose: To support innovative research on coagulation/hematology. This year, Aniara is requesting proposals for projects that deal specifically with Ehlers-Danlos syndrome (EDS) and its effects on hemostasis and thrombosis.
• Eligibility: Established researchers (PhD faculty or equivalent), student or trainee at an academic organization or institution in North America or Scandinavia. Applicants with a minimum of three peer-reviewed publications preferred.

Lustgarten Foundation  – Robert F. Vizza Clinical Accelerator Initiative

• Due: November 3, 2025 (LOI)
• Funding: $300,000
• Project Period: Over 3 years
• Purpose: This grant is intended to provide academic, clinical researchers the opportunity to propose science-driven concepts focused on advancing the development of new therapies for pancreatic cancer patients while furthering our understanding of disease biology.
• Eligibility: Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent degree and have a faculty position or equivalent at a college, university, medical institution, or other research facility. PIs should be conducting significant pancreatic cancer and/or related research, have a demonstrated track record of significant contributions to the field, evidenced by publications, peer-reviewed funding and an ability to advance projects to clinical impact. Collaboration with outside institutions including the Lustgarten Translational Advisory Group and other Lustgarten Foundation-Funded Investigators is required.

Cystic Fibrosis Foundation – Medical Resident Research Award

• Due: November 14, 2025
• Funding: Up to $10,000
• Project Period: 1 year
• Purpose: To introduce residents to research through participation in a CF-relevant research project and to spark interest in a career in CF research or as a CF care provider. Priority will be given to projects that will lead to increased understanding of disease mechanisms, pathophysiology, and prevention, and the development of treatment strategies.
• Eligibility: U.S. citizens, permanent residents, or non-U.S. citizens working in a U.S.-based, non-profit or academic institution. Applicants must have completed medical training, hold an MD, DO, or equivalent, and be enrolled in an ACGME accredited residency program in the U.S. for the duration of the award. International applicants must be able to obtain the appropriate visas for application and be certified by the Educational Commission for Foreign Medical Graduates (ECFMG).

Cancer Research Institute – CRI Technology Impact Award

• Due: November 15, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support collaborations between technology, developers and clinical cancer immunologists to generate proof-of-principle of a novel platform technology in bioinformatics that can accelerate the field’s efforts in developing immunotherapies that are effective for all cancer patients.
• Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation or provide documentation from their institution along with the Letter of Intent confirming they will hold the position of assistant professor or higher by the time of award start date.

The Gerber Foundation – Spring Grant Round – Novice Grants Only

• Due: November 15, 2025 (Concept papers due)
• Funding: $30,000
• Project Period: Not specified
• Purpose: To support projects that focus on infants and children. Priority will be given to projects that when implemented, will improve nutrition, care and development of infants and young children from the first year before birth to three years of age.
• Eligibility: Applicants may be physicians, PhD candidates, PharmD candidates, and equivalent (and individuals in a residency, postdoctoral, or fellowship training program or those with no more than one year post training). K01 awardees are not eligible. An assigned mentor is required.

KidneyCure – KidneyCure Transition to Independence Grants Program

• Due: November 20, 2025
• Funding: $75,000
• Project Period: 1 year
• Purpose: To provide support for the development and career advancement to research independence of young faculty in the field.
• Eligibility: Active ASN members with and MD, DO, PhD or equivalent working in North America, Central America, or the Caribbean, who are within 10 years of their initial faculty appointment. Appointment to full-time faculty and support as an independent researcher must be confirmed by the department chair. The proposed project must be independent of previous projects with a mentor. Applicants may not have more than $250,000 in annual direct costs in external grant support (including KidneyCare funds), at the time of the award. 75% protected time required.

December

American Cancer Society – Clinician Scientist Development Grant (CSDG)

• Due : December 1, 2025
• Funding: $135,000 a year
• Project Period: 3 to 5 years
• Purpose: Supports full-time clinician faculty members in becoming independent investigators as clinician scientists.
• Eligibility: Applicants who work at a US academic institution or eligible non-profit  who have a doctoral degree and active clinical license who participate in clinical care and are not a current or former principal investigator of an individual mentored training grant and have not been a PI on an R-level or equivalent grant are eligible.

American Cancer Society – Postdoctoral Fellowships (PF)

• Due : December 1, 2025
• Funding: $66,000, $68,000, and $70,000, plus $4,000 fellowship annually (plus $1,500 travel allowance in final year)
• Project Period: Up to 3 years
• Purpose: To support new investigators in research training programs to position them for independent careers in cancer research.
• Eligibility: Applicants with doctoral degrees (less than 4 years) who do not have a faculty appointment and work at a US academic institution or eligible non-profit are eligible. U.S. citizenship, permanent residency, or appropriate visa when you submit your application is required.

American Cancer Society – Research Scholar Grants

• Due : December 1, 2025
• Funding: Up to$215,000 per year
• Project Period: Up to 4 years
• Purpose: To support independent, self-directed researchers working at an U.S. academic institution or eligible non-profit organizations.
• Eligibility: Awards available to support investigators at all levels who have been appointed as independent, full-time faculty less than 10 years ago. Applicant’s institution must provide space and other resources needed by independent investigators.

American Cancer Society – RFA: Leukemia Exploration and Prevention Grant Program (LEAP)

• Due : December 1, 2025
• Funding: Up to $430,000 per year
• Project Period: Up to 4 years
• Purpose: RUNX1 Research Program and the American Cancer Society (ACS) have partnered to support projects that deepen our understanding of the mechanisms that cause each leukemogenic step (projects should consider experimental designs that address both cell-autonomous and cell-nonautonomous factors), and projects that are high-risk with strong scientific rationale to pursue a cancer interception treatment.
• Eligibility: PIs/teams must work at a U.S. academic institution or eligible non-profit organization and can be full-time independent investigators at any career stage.
  LEAP-Research Scholar Grant – supports an independent research project (up to $215,000 per year for independent, self-directed researchers).
• LEAP Team Award – supports an interdisciplinary, synergistic team research project that will accelerate scientific advancement and clinical benefit (up to $430,000 per year).

American College of Gastroenterology (ACG) Institute for Clinical Research and Education  & American College of Gastroenterology – 2026 Junior Faculty Development Award

• Due : December 1, 2025
• Funding: $450,000
• Project Period: 3 years
• Purpose: To support junior investigators pursuing independent clinical research careers in gastroenterology or hepatology.
• Eligibility: ACG members who are full-time junior faculty (less than 7 years post GI or Hepatology fellowship training) at a U.S.- or Canadian-based university, medical school or health care institution who hold an MD, MBBS, or DO are eligible. 50% protected time and a preceptor who can provide mentorship is required.

American College of Gastroenterology (ACG) Institute for Clinical Research and Education & American College of Gastroenterology – 2026 Established Investigator Bridge Funding Award RFA

• Due : December 1, 2025
• Funding: $300,000
• Project Period: 2 years
• Purpose: To provide short-term support for established clinical gastroenterology or hepatology investigators while they await federal program funding for their independent research program.
• Eligibility: ACG members who are U.S.- or Canadian-based physicians working as full-time faculty in a astroenterology or hepatology department at a university, medical school or other healthcare institution university. Evidence of recently concluded federal clinical or translational research award as the PI within the last 3 years in gastroenterology or hepatology, such as NIH R01, K-award, or VA Merit Award. National Science Award, Department of Defense and CIHR multi-year project grant awards of equivalency will be considered. Applicants must provide evidence of an ongoing renewal application for federal funding (eRA commons routing information or letter of intent from institutional grant awards office). A letter from the Division Chief or Department Chair must certify that the award will provide 30% protected time to the recipient regardless of the amount budgeted for salary under the terms of the award.

Association for the Advancement of Blood & Biotherapies  – Early Career Scientific Research Grants Program

• Due : December 1, 2025
• Funding: Up to $100,000
• Project Period: Up 2 years
• Purpose: To support investigator-initiated original research related to blood banking, transfusion medicine and biotherapies with a strong likelihood of yielding meaningful data, and to fund researchers on a path towards research independence. Innovative proposals and new projects will be given priority.
• Eligibility: Early career investigators who have completed a terminal research degree or medical residency within 10 years of grant application submission deadline (MD or PhD, medical technologist, transfusion medicine or biotherapies professional), and has not yet been awarded a substantial grant (such as an R01) are eligible to apply

Cancer Research Institute – Clinic & Laboratory Integration Program (CLIP)

• Due : December 1, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation (CF), CRI also invites LOIs focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine.
• Eligibility: : Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award start date and be qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.

RUNX1 Research Grant Program & Alex’s Lemonade Stand Foundation for Childhood Cancer – RUNX1 RARE Grant Program – Research Accelerating RUNX1 Exploration

• Due : December 11, 2025
• Funding: $250,000
• Project Period: Over 2 years
• Purpose: To fund research that will accelerate development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis).
• Eligibility: Applicants must have MD, PhD, MD/PhD (DO, MBBS or equivalent) and research experience working in, and a deep understanding of, normal or malignant hematopoiesis and/or immunology. Funds will be granted to non-profit organizations only. PIs can have other grants during the award period but must provide clear documentation of mechanisms to avoid scientific and budgetary overlap.

Jay L. Smith Foundation – Grants

• Due : December 31, 2025 (pre-proposal)
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support research, programs, education and outreach in various areas to include dementia & Alzheimer’s disease, health care access and delivery, elderly care, suicide prevention, and cancer research.
• Eligibility: U.S.-based nonprofit organizations may apply.

Awards

October

American Academy of Neurology – Wayne A. Hening Sleep Medicine Investigator Award

• Due : October 21, 2025
• Prize: $1,000
• Project Period: Not specified
• Purpose:  The award is sponsored by the American Academy of Neurology and endowed by UCB, Inc., Lilly USA, Elite Home Medical & Respiratory, Inc., Raleigh Neurology Associates, and friends of Dr. Wayne A. Hening. It rewards productivity of early career investigators  and emphasizes the essential role of neurology in sleep medicine. Recipient is expected to give a 10-minute presentation based on the selected manuscript during a scientific session at the 2026 AAN Annual Meeting.
• Eligibility: Applicants must be no more than 10 years from completion of most recent training program and no higher than the rank of assistant professor. Board certification and AAN membership not necessary. Industry employees are not eligible.

December

Challenge  Works, the Motor Neurone Disease Association & partners – Longitude Prize on ALS

• Due : December 3, 2025
• Prize: Up to $10M
• Project Period: 5 years
• Purpose: An international program that seeks to incentivize the use of AI-based approaches to transform therapeutic discovery for treating amyotrophic lateral sclerosis (ALS) by global multidisciplinary teams to identify, prioritize, and validate high-potential drug targets.
• Eligibility: AI experts, computational biologists and bioinformaticians, neurodegenerative disease and ALS researchers, Biotechnology, techbio and pharmaceutical companies, Data scientists and engineers, and clinical experts and medical researchers may apply.